林业发展局批准对猪对人的肾移植进行第一次人体试验,以缓解器官短缺。 FDA approves first human trials for pig-to-human kidney transplants to ease organ shortage.

林业发展局批准了由生物技术公司eGenesis开发的对转基因猪的肾移植的首次人类临床试验。 The FDA has approved the first human clinical trials for kidney transplants from genetically modified pigs, developed by biotech company eGenesis. 这些试验旨在解决器官严重短缺的问题,有超过10万美国人等待移植。 These trials aim to address the critical shortage of organs, with over 100,000 Americans waiting for transplants. 对猪肾进行基因改造是为了使其与人体接受者更加相容,从而有可能克服先前的器官排斥和安全问题。 The genetic modifications to the pig kidneys are designed to make them more compatible with human recipients, potentially overcoming previous issues of organ rejection and safety concerns.